McCann Health bolsters leadership team in Europe
McCann Health has announced three key appointments to its leadership in Europe.
Nick Bartlett joins as president of North Europe in a newly created role that oversees UK, France and McCann Health Consulting.
At the European leadership level, Nick will be joining Effie Baoutis, president of West Europe, who oversees countries in the region including Germany.
Nick brings over 20 years of experience in managing high-performance digital operations and consultancies in healthcare service companies, including Syneos Health, Publicis Health and most recently Bionical Group.
“I’m delighted to be joining such a progressive leader in the healthcare field,” said Nick Bartlett. “I see huge potential in bringing McCann’s consumer expertise to broaden, engage and deepen our capabilities in the specialist healthcare market and contribute to international growth of this sector.”
In the London team, Jonathan Kukathasan has been promoted to managing director from his previous position as general manager and Rob Fuller joins from Havas Lynx as head of planning for McCann Health London.
McCann Health said that during his 14 years at the company, Jonathan has “strengthened client relationships, championed a culture of creativity and shown a natural flair as a leader which has contributed to the London team’s exponential expansion in the past two years”.
Rob has worked in healthcare for over a decade with client-side experience for brands such as Merck, J&J Consumer Health and Reckitt Benckiser in addition to his most recent role at Havas Lynx.
“Nick and the new leadership team will allow us to drive integration across the agency and maximise synergies to better respond to the evolving needs of our clients and the rapidly changing world of healthcare,” said John Cahill, group chief executive officer.
McCann’s Health division has twice won Network of the Year at Cannes Lions Health and more recently picked up Most Awarded Network 2018 at the Creative Floor Healthcare Awards.
Don't miss your daily pharmaphorum news.
SUBSCRIBE free here.